β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H by Wong, CM et al.
Title β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H
Author(s) CHENG, Y; GAO, W; Tang, HMV; Deng, J; Wong, CM; Chan, CP;Jin, D
Citation Scientific Reports, 2016, v. 6, p. 23938:1-16
Issued Date 2016
URL http://hdl.handle.net/10722/234400
Rights This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
1Scientific RepoRts | 6:23938 | DOI: 10.1038/srep23938
www.nature.com/scientificreports
β-TrCP-mediated ubiquitination 
and degradation of liver-enriched 
transcription factor CREB-H
Yun Cheng1,2, Wei-Wei Gao1,2, Hei-Man Vincent Tang1,2,3, Jian-Jun Deng1,2,4, Chi-Ming Wong3,5, 
Chi-Ping Chan1,2,3 & Dong-Yan Jin1,2,3
CREB-H is an endoplasmic reticulum-resident bZIP transcription factor which critically regulates 
lipid homeostasis and gluconeogenesis in the liver. CREB-H is proteolytically activated by regulated 
intramembrane proteolysis to generate a C-terminally truncated form known as CREB-H-ΔTC, which 
translocates to the nucleus to activate target gene expression. CREB-H-ΔTC is a fast turnover protein 
but the mechanism governing its destruction was not well understood. In this study, we report on 
β-TrCP-dependent ubiquitination and proteasomal degradation of CREB-H-ΔTC. The degradation of 
CREB-H-ΔTC was mediated by lysine 48-linked polyubiquitination and could be inhibited by proteasome 
inhibitor. CREB-H-ΔTC physically interacted with β-TrCP, a substrate recognition subunit of the  
SCFβ-TrCP E3 ubiquitin ligase. Forced expression of β-TrCP increased the polyubiquitination and 
decreased the stability of CREB-H-ΔTC, whereas knockdown of β-TrCP had the opposite effect. An 
evolutionarily conserved sequence, SDSGIS, was identified in CREB-H-ΔTC, which functioned as the 
β-TrCP-binding motif. CREB-H-ΔTC lacking this motif was stabilized and resistant to β-TrCP-induced 
polyubiquitination. This motif was a phosphodegron and its phosphorylation was required for β-TrCP 
recognition. Furthermore, two inhibitory phosphorylation sites close to the phosphodegron were 
identified. Taken together, our work revealed a new intracellular signaling pathway that controls 
ubiquitination and degradation of the active form of CREB-H transcription factor.
CREB-H, also known as cAMP responsive element-binding protein 3-like 3 (CREB3L3), is an endoplasmic 
reticulum (ER) membrane-bound transcription factor which is mainly expressed in the liver and small intes-
tine1,2. CREB-H belongs to the CREB3 subfamily of bZIP proteins and the other subfamily members are CREB3/
Luman, CREB3L1/OASIS, CREB3L2/BBF2H7 and CREB3L4/AIBZIP3. CREB-H is activated by regulated 
intramembrane proteolysis to liberate a constitutively active form known as CREB-H-ΔTC, which contains the 
N-terminal transactivation and DNA-binding domains but lacks the C-terminal transmembrane and luminal 
domains. CREB-H-ΔTC translocates into the nucleus to activate target gene expression4,5. Currently, it has been 
shown that CREB-H mRNA synthesis is induced by metabolic stimuli, such as fatty acids, fasting, peroxisome 
proliferator-activated receptor α (PPAR-α ) and glucocorticoids6–8. CREB-H and other transcription factors of the 
CREB3 subfamily are structurally related to ATF6 and are therefore also thought to be activated proteolytically in 
response to ER stress9. However, this remains controversial because the generation of CREB-H-ΔTC is not acti-
vated by ER stressors such as thapsigargin and tunicamycin10. On the contrary, tunicamycin perturbs N-linked 
glycosylation in the luminal domain of CREB-H, which is required for optimal proteolytic activation11.
CREB-H is a multifunctional protein which regulates lipid metabolism, iron homeostasis, gluconeogene-
sis, cell secretion, cell growth and acute phase response4,5,7,12–14. Growing evidence suggests that CREB-H plays 
important roles in lipid metabolism and whole-body energy homeostasis15,16. Transcriptomic analysis has 
revealed a subset of CREB-H-regulated genes that are critically involved in lipid metabolic processes12,17,18. The 
CREB-H knockout mice exhibit marked hypertriglyceridemia (HTG), which is caused by impaired lipoprotein 
lipase-mediated triglyceride clearance12. Heterozygous non-synonymous or insertional mutations of CREB-H 
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have also been found in HTG patients12,19. On the other hand, expression of CREB-H-ΔTC in mouse models of 
obesity and diabetes has been shown to have beneficial effects, which are mediated in part through the activa-
tion of fibroblast growth factor 21 (FGF21), a hepatokine and a potential therapeutic agent for obesity-related 
medical conditions16,18. CREB-H also promotes lipid droplet formation and triglyceride storage in liver tissues 
by increasing the expression of a lipid droplet-associated protein named fat-specific protein 27 β (FSP27β )20. 
In addition, adipose tissue-derived fatty acids are known to regulate the expression of FGF21 and other genes 
through CREB-H21. Other CREB-H-regulated genes include APOA4, which encodes apolipoprotein A4 involved 
in the activation of lipoprotein lipase10,12, and MMP13, which encodes matrix metallopeptidase 13 controlling 
extracellular matrix remodeling, cell secretion and mineral homeostasis14. CREB-H has a significant impact on 
hepatic function and its activity has to be tightly regulated. CREB-H-ΔTC is the active form of CREB-H that acti-
vates target genes directly. We and others have previously found that CREB-H-ΔTC is a short-lived protein4,5,11,22. 
This might help to ensure that the activation of its target genes is transient and the impact on lipid homeostasis is 
not long-lasting. However, exactly how the degradation of CREB-H-ΔTC is regulated remains to be elucidated.
The ubiquitin-proteasome system is one major pathway for intracellular protein degradation23. A pro-
tein is ubiquitinated by three sequential enzymatic reactions catalyzed by ubiquitin-activating enzyme E1, 
ubiquitin-conjugating enzyme E2 and ubiquitin ligase E3. Whereas lysine 48-linked polyubiquitination normally 
leads to proteasome-mediated degradation of the target protein, lysine 63-linked polyubiquitination commonly 
results in alteration of protein function or subcellular localization24,25. In the ubiquitin-proteasome system, E3 
ubiquitin ligase is the crucial component governing substrate specificity. More than 600 genes in the human 
genome encode putative E3 ubiquitin ligases26. The SKP1-CUL1-F-box (SCF) protein complexes are the largest 
family of E3 enzymes. Essential components of these complexes include scaffold protein cullin1 (CUL1), adaptor 
protein SKP1, RING finger protein RBX1 and variable F-box proteins. The F-box protein can recruit the specific 
substrate through its WD40 or LRR domain and bind with other SCF components through its F-box domain27,28. 
β -transducin repeat containing protein (β -TrCP) is a well-studied F-box protein with two paralogs in mammals, 
β -TrCP1 (Fbxw1) and β -TrCP2 (Fbxw11). The biological properties of the two paralogs are indistinguishable. 
Most β -TrCP substrates contain a consensus DSGφ xS degron, in which φ represents a hydrophobic amino acid 
and x could be any amino acid. The serine residues in the degron are phosphorylated. Recognition of the phos-
phodegron by β -TrCP leads to ubiquitination of the substrate29–31. β -TrCP regulates various cell signaling path-
ways by degrading key signal transducers such as β -catenin for Wnt signaling and Iκ Bα for NF-κ B signaling32,33. 
In addition, human papillomavirus type 16 and a few other viruses are capable of inhibiting β -TrCP function to 
facilitate their own replication in host cells34. On the other hand, human immunodeficiency virus type 1 Vpu 
protein can recruit β -TrCP to target its cellular receptor CD4 for degradation35.
Degradation of membrane-bound CREB-H is thought to be mediated through the ER-associated protein 
degradation (ERAD) pathway36. However, CREB-H-ΔTC is a nuclear protein with a fast turnover rate and its deg-
radation is plausibly governed by other mechanisms. It is particularly noteworthy that CREB3L1 and CREB3L2 
of the same subfamily are targeted by Fbxw7 ubiquitin ligase to undergo SCF-dependent degradation37. Both 
wild-type and active forms of CREB3L1 and CREB3L2 are degraded by Fbxw7. We therefore set out to investi-
gate whether CREB-H-ΔTC might also be degraded by SCF. We found that CREB-H-ΔTC is indeed targeted by 
SCFβ-TrCP. We also identified two degron-proximal inhibitory phosphorylation sites in CREB-H-ΔTC. When our 
study was completed, an independent group also reported SCFβ-TrCP-mediated degradation of CREB-H-ΔTC38. 
The two studies corroborate with each other to demonstrate a new mechanism for regulated destruction of the 
active form of CREB-H.
Results
Degradation of CREB-H-ΔTC by the ubiquitin-proteasome pathway. CREB-H is known to be 
stabilized by proteasome inhibition and degraded through the ERAD pathway36. However, membrane-bound 
CREB-H is transcriptionally inactive and CREB-H-ΔTC is the physiologically active form that activates tran-
scription in the nucleus. We and others have found that CREB-H-ΔTC has a much shorter half-life than 
full-length CREB-H4,5,22. Because the active forms of CREB3L1 and CREB3L2 are also degraded through the 
ubiquitin-proteasome pathway37, we asked whether the fast turnover of CREB-H-ΔTC might also be governed by 
the same mechanism. Treatment of cells with proteasome inhibitor MG132 over a time course led to progressively 
increasing accumulation of CREB-H-ΔTC, indicating the requirement of the 26 S proteasome for CREB-H-ΔTC 
degradation (Fig. 1A, lanes 1–5).
To verify the polyubiquitination status of CREB-H-ΔTC and the type of ubiquitin linkage, we compared the 
ubiquitination patterns of CREB-H-ΔTC immunoprecipitated from HEK293T cells overexpressing wild-type and 
mutant ubiquitin. The ubiquitination smear of CREB-H-ΔTC was evident when wild-type ubiquitin but not its 
lysine-free mutant K0 was overexpressed (Fig. 1B, lanes 3 and 4). Furthermore, whereas the ubiquitination ladder 
of CREB-H-ΔTC was unaffected by ubiquitin mutant 63R, in which lysine 63 had been replaced by arginine, the 
48R mutant of ubiquitin lacking lysine 48 did not support polyubiquitination of CREB-H-ΔTC (Fig. 1B, lanes 
5 and 6). Thus, the polyubiquitin chain of CREB-H-ΔTC was lysine 48-linked. In addition, similar results in 
support of lysine 48-linked polyubiquitination were also obtained for full-length CREB-H (Fig. 1C). These data 
suggested that both CREB-H-ΔTC and CREB-H might be degraded through the ubiquitin-proteasome pathway.
Identification of a putative β-TrCP recognizing motif in CREB-H-ΔTC. Because CREB3L1 and 
CREB3L2 are degraded by SCF37, we sought to shed light on the identity of the E3 ubiquitin ligase for CREB-H-ΔTC 
by searching its sequence for recognition motifs by F-box proteins. Our bioinformatic analysis was fruitful. F-box 
protein β -TrCP recognizes a conserved degradation motif DSGφ xS with phosphoserines. Inspection of the 
CREB-H-ΔTC amino acid sequence revealed an evolutionarily conserved sequence, DSGIS, which resembles the 
canonical β -TrCP degradation motif (Fig. 2A). This putative β -TrCP recognizing motif located at residues 86–90 of 
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CREB-H is identical or very similar to other β -TrCP degrons found in erythropoietin receptor, rotavirus nonstruc-
tural protein NSP1, transcription factor Nrf2, β -catenin and transcriptional co-activator YAP1 (Fig. 2B). Moreover, 
multiple alignment of CREB-H-ΔTC among different species revealed two additional clusters of evolutionarily 
conserved serine and threonine residues flanking the DSGIS motif: SxxxSxxxSxxxS located at residues 73–85 and 
SxxxxS/T located at residues 95–100 (Fig. 2A). Because phosphorylation of degron-proximal serine and threonine 
residues critically affects β -TrCP recognition in many substrates29,30, it would not be surprising that these residues 
in CREB-H-ΔTC might also have a regulatory function in β -TrCP-dependent degradation. In addition, identical 
or very similar β -TrCP recognizing motifs were also found in other members of the CREB3 subfamily (Fig. 2B).
SCFβ-TrCP E3 ligase mediates degradation of CREB-H-ΔTC. To test whether SCFβ-TrCP is a bona fide E3 
ubiquitin ligase responsible for CREB-H-ΔTC degradation, several lines of experiments were performed. First, we 
explored the interaction between CREB-H-ΔTC and SCFβ-TrCP by reciprocal co-immunoprecipitation. Detection of 
β -TrCP in the CREB-H-ΔTC immunoprecipitate and vice versa indicated the interaction between CREB-H-ΔTC 
and β -TrCP (Fig. 2C,D). Co-immunoprecipitation assay also indicated the association of CREB-H-ΔTC with 
two other components of the SCF complex: scaffold protein CUL1 and RING finger protein RBX1 (Fig. 2E,F). 
Simultaneous detection of β -TrCP, CUL1 and RBX1 in the CREB-H-ΔTC immunoprecipitate further suggested 
that CREB-H-ΔTC was bound to the SCF complex (Fig. 2G). Plausibly, β -TrCP functions as a substrate recogni-
tion protein to adapt CREB-H-ΔTC to other components of the SCF complex such as CUL1 and RBX1.
Figure 1. Degradation of CREB-H-ΔTC by the ubiquitin-proteasome pathway. (A) HEK293T cells 
expressing V5-tagged CREB-H-ΔTC (V5-ΔTC) were treated with 10 μM MG132 for 0.5, 1, 2 and 6 hours  
before harvest. Protein samples were separated by SDS-PAGE and probed with anti-V5 and anti-β -actin.  
(B,C) MYC-ubiquitin (MYC-Ub) and the indicated mutants were individually cotransfected with CREB-H-
ΔTC or CREB-H into HEK293T cells. Immunoprecipitation was performed with anti-V5. Precipitates and 
inputs (10%) were analyzed by immunoblotting with anti-MYC. GAPDH was detected as an internal control. 
Ub: ubiquitin. K0: lysine free ubiquitin. 48R: ubiquitin with replacement of lysine 48 by arginine. 63R: ubiquitin 
with replacement of lysine 63 by arginine.
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Figure 2. Interaction between CREB-H-ΔTC and SCFβ-TrCP. (A) Sequence alignment of CREB-H homologs 
from different species. The predicted β -TrCP-recognizing motif (DSGφ S) and the adjacent highly conserved 
serine-threonine residues are framed and highlighted. Identical residues are denoted by asterisks (*), whereas 
colons (:) and periods (.) indicate strong and weak similarity, respectively. φ : hydrophobic residue. x: any 
residue. Hs: Homo sapiens (human). Mm: Mus musculus (house mouse). Rn: Rattus norvegicus (Norway rat). 
Bt: Bos taurus (bovine). Dr: Danio rerio (zebrafish). Gg: Gallus gallus (chicken). (B) Sequence alignment of 
CREB-H with known β -TrCP substrates (upper) and other CREB3 subfamily proteins (lower). The β -TrCP 
recognizing motif is indicated. EPOR: erythropoietin receptor. RV-NSP1: rotavirus nonstructural protein NSP1. 
(C,D) Interaction between CREB-H-ΔTC and β -TrCP. Reciprocal co-immunoprecipitation was performed 
with V5-CREB-H-ΔTC (V5-ΔTC) and FLAG-β -TrCP (FLAG-β -T) or FLAG-CREB-H-ΔTC (FLAG-ΔTC) 
and V5-β -TrCP (V5-β -T) expressed in HEK293T cells. Cell lysates were immunoprecipitated with anti-V5 
and the precipitates were immunoblotted with anti-FLAG and anti-V5. The input cell lysates (10%) were also 
probed with anti-FLAG and anti-V5. (E,F) Interaction of CREB-H-ΔTC with CUL1 and RBX1. Lysates from 
transfected HEK293T cells were immunoprecipitated with anti-V5 and the precipitates were analyzed by 
immunoblotting with anti-V5 and anti-MYC. The input lysates (10%) were also detected with anti-V5 and anti-
MYC. (G) Interaction of CREB-HΔTC with β -TrCP, CUL1 and RBX1. The anti-V5 immunoprecipitates were 
probed with anti-MYC, anti-FLAG and anti-V5.
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Second, we investigated how β -TrCP might influence the steady-state expression and polyubiquitination of 
CREB-H-ΔTC. When we expressed β -TrCP and CREB-H-ΔTC in HEK293T cells, a modest or no decrease of 
CREB-H-ΔTC was observed (Fig. 2C,D). Bearing in mind that ubiquitin might be limiting, we overexpressed 
ubiquitin in cells and found that the steady-state level of CREB-H-ΔTC was substantially reduced when β -TrCP 
and ubiquitin were expressed (Fig. 3A, lanes 1 and 2). In contrast, expression of β -TrCP-ΔFbox, a dominant inac-
tive β -TrCP mutant deleted of F-box and deficient for binding with other SCF components, had no influence on 
the steady-state expression of CREB-H-ΔTC (Fig. 3A, lane 3). Consistent with this pattern, knockdown of β -TrCP 
with two independent small interfering RNAs (siRNAs) elevated the steady-state levels of CREB-H-ΔTC protein 
(Fig. 3B, lanes 2 and 3). Cycloheximide chase assay, in which cycloheximide was added to block de novo protein 
synthesis, was performed and the results confirmed the stabilization of CREB-H-ΔTC protein in β -TrCP knock-
down cells (Fig. 3C, lanes 5–8). Furthermore, in vivo polyubiquitination assay indicated that the ubiquitination 
smear of CREB-H-ΔTC was more pronounced when β -TrCP was expressed (Fig. 3D, lanes 3 and 4). However, 
the expression of β -TrCP-ΔFbox decreased polyubiquitination of CREB-H-ΔTC and increased its steady-state 
expression (Fig. 3D, lane 5).
Finally, we compared the stability of CREB-H-ΔTC in HepG2 cells with or without β -TrCP overexpression by 
cycloheximide chase assay. Diminution of CREB-H-ΔTC was more pronounced in the presence of β -TrCP than 
in its absence (Fig. 4A, lanes 6–8). Taken together, our results supported the notion that CREB-H-ΔTC is a novel 
substrate of SCFβ-TrCP E3 ubiquitin ligase.
Characterization of β-TrCP phosphodegron in CREB-H-ΔTC. To test whether the putative β -TrCP 
destruction motif was indeed influential in the control of CREB-H-ΔTC stability, we deleted the DSGIS sequence 
and generated a CREB-H-ΔTC mutant designated CREB-H-ΔTC-Δ81–90. Three experiments were performed 
to characterize this mutant. First, the half-lives of CREB-H-ΔTC and CREB-H-ΔTC-Δ81–90 were compared 
in β -TrCP-expressing HepG2 cells. Whereas CREB-H-ΔTC was degraded rapidly in the presence of β -TrCP 
(Fig. 4A, lanes 6–8), the amount of CREB-H-ΔTC-Δ81–90 remained constant in β -TrCP-expressing cells 
Figure 3. Influence of β-TrCP overexpression or suppression on steady-state level and polyubiquitination 
of CREB-H-ΔTC. (A) Immunoblotting of cell lysates derived from HEK293T cells expressing β -TrCP 
(FLAG-β -T) or β -TrCP-ΔFbox (FLAG-ΔF), ubiquitin (Ub) and CREB-H-ΔTC (ΔTC). (B) Immunoblotting of 
cell lysates derived from HEK293T cells transfected with two independent siRNAs targeting β -TrCP (siβ -T#1 
and siβ -T#2). siGFP served as a control. (C) Analysis of protein stability by cycloheximide chase assay. 
HEK293T cells cotransfected with siβ -T#1 and CREB-H-ΔTC plasmid were treated with 200 μM cycloheximide 
(CHX) for 3, 5 and 8 hours before harvest. Protein samples were analyzed by SDS-PAGE and probed with the 
indicated antibodies. (D) Polyubiquitination analysis. Lysates from HEK293T cells expressing the indicated 
proteins were immunoprecipitated with anti-V5 and the precipitates were analyzed by immunoblotting with 
anti-MYC, anti-FLAG and anti-V5. The inputs (10%) were probed with anti-V5 and anti-GAPDH.
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treated with cycloheximide (Fig. 4A, lanes 13–16). Consistent with a longer half-life of CREB-H-ΔTC-Δ81–90 
in β -TrCP-expressing cells (Fig. 4A), its steady-state level did not drop in response to β -TrCP overexpression 
(Fig. 4B, lanes 3 and 4). Unlike CREB-H-ΔTC-Δ81–90, CREB-H-ΔTC was almost undetectable when β -TrCP 
was overexpressed (Fig. 4B, lanes 1 and 2). Thus, the DSGIS motif is indeed required for β -TrCP-dependent 
degradation of CREB-H-ΔTC. Second, the interaction between β -TrCP and CREB-H-ΔTC-Δ81–90 was assessed 
by co-immunoprecipitation. The absence of endogenous or overexpressed β -TrCP in the CREB-H-ΔTC-Δ81–90 
immunoprecipitate indicated the loss of β -TrCP-binding ability of the degron-deleted mutant of CREB-H-ΔTC 
(Fig. 4C, lane 3 and Fig. 4D, lane 5). Finally, in vivo polyubiquitination assay was performed and β -TrCP was 
Figure 4. CREB-H-ΔTC-Δ81-90 was resistant to β-TrCP-induced degradation and polyubiquitination.  
(A) Protein stability. HepG2 cells expressing the indicated proteins were treated with 200 μM cycloheximide 
(CHX) for 1, 3 and 5 hours before harvest. Protein samples were collected, analyzed by SDS-PAGE and 
immunoblotted with anti-FLAG, anti-V5 and anti-GAPDH. (B) Steady-state protein expression. CREB-H-
ΔTC (V5-ΔTC) or CREB-H-ΔTC-Δ81-90 (V5-Δ81-90), β -TrCP (FLAG-β -T) and ubiquitin (Ub) constructs 
were transfected into HEK293T cells. Cell lysates were immunoblotted with anti-V5 and anti-FLAG. GAPDH 
was detected as an internal control. (C,D) Immunoprecipitation. CREB-H-ΔTC (V5-ΔTC) or CREB-H-
ΔTC-Δ81-90 (V5-Δ81-90) construct was transfected into HEK293T cells or HEK293T cells expressing 
FLAG-β -TrCP (FLAG-β -T). Cell lysates were immunoprecipitated with anti-V5. The inputs (10%) and the 
immunoprecipitates were analyzed by SDS-PAGE and probed with anti-V5 and either anti-β -TrCP or anti-
FLAG. (E) In vivo polyubiquitination. HEK293T cells were transfected with constructs expressing the indicated 
proteins. Cell lysates were immunoprecipitated with anti-V5 and the precipitates were probed with anti-MYC, 
anti-FLAG and anti-V5. The input samples (10%) were probed with anti-FLAG, anti-V5 and anti-GAPDH.
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found to have minimal influence on polyubiquitination of CREB-H-ΔTC-Δ81–90 (Fig. 4E, lane 5). In the con-
trol group with overexpression of β -TrCP, polyubiquitination of CREB-H-ΔTC was much more robust and 
CREB-H-ΔTC protein was marginally detected in both the input and the precipitate (Fig. 4E, lane 3). Hence, our 
results consistently demonstrated the essentiality of the DSGIS degron in β -TrCP binding, polyubiquitination and 
degradation of CREB-H-ΔTC.
For most β -TrCP substrates, phosphorylation of the β -TrCP degron is usually required for their bind-
ing to β -TrCP29,30. With this in mind we constructed and characterized different phosphorylation mutants 
of CREB-H-ΔTC (Fig. 5A) to determine whether the interaction between β -TrCP and CREB-H-ΔTC is 
phosphorylation-dependent.
First, we generated a non-phosphorylatable mutant CREB-H-ΔTC-A4, in which four serine residues S81, S85, 
S87 and S90 within or near the DSGIS degron had been replaced by alanine. On the contrary, a phosphomimetic 
mutant CREB-H-ΔTC-D4 with the same four serine residues substituted by aspartate was also made (Fig. 5A). 
We then compared the β -TrCP-binding ability of CREB-H-ΔTC, CREB-H-ΔTC-A4 and CREB-H-ΔTC-D4. In 
sharp contrast to CREB-H-ΔTC-A4, which lost its β -TrCP-binding activity almost completely (Fig. 5B, lane 4), 
CREB-H-ΔTC-D4 was fully competent for binding with β -TrCP (Fig. 5B, lane 6). These results supported the 
requirement of degron phosphorylation for β -TrCP recognition.
Second, further mutational analysis was carried out to identify the serine residues, the phosphoryl-
ation of which would be critical for β -TrCP recognition. Interestingly, whereas CREB-H-ΔTC-A3 with 
non-phosphorylatable S85A, S87A and S90A did not interact with β -TrCP, CREB-H-ΔTC-A2 carrying 
non-phosphorylatable S87A and S90A was still capable of binding to β -TrCP (Fig. 5C, lanes 3 and 4). Considered 
together the full ability of CREB-H-ΔTC-S81A S85A harboring non-phosphorylatable S81A and S85A to 
bind with β -TrCP (Supplementary Figure 1, lane 7), these results were compatible with one model in which 
phosphorylation at S85, S87 and S90 might be minimally required for β -TrCP binding. In other words, the 
β -TrCP-recognizing motif in CREB-H-ΔTC is SDSGIS. Consistent with its loss of β -TrCP-binding ability, the 
steady-state level (Fig. 5D, lanes 2 and 4) and transcriptional activity (Fig. 5E, group 3) of CREB-H-ΔTC-A3 were 
elevated. Additionally, although less S95A T100A mutant was detected in the precipitate, the mutation had min-
imal impact on the binding with β -TrCP (Fig. 5C, lane 6). Thus, these sites might not be critical in the regulation 
of β -TrCP recognition.
Finally, we explored how phosphorylation within the SDSGIS degron might affect transcriptional activity 
of CREB-H-ΔTC. S87 and S90 within the SDSGIS motif were replaced one by one by alanine and aspartate 
(Fig. 5A). Luciferase reporter assay was performed on the CRE promoter which is known to be highly responsive 
to CREB-H-ΔTC. CREB-H-ΔTC-S90A displayed increased transcriptional activity but the CREB-H-ΔTC-S90D 
mutation had inhibitory effect (Fig. 5E, groups 6 and 7). CREB-H-ΔTC-S87A was also transcriptionally more 
active than CREB-H-ΔTC-S87D (Fig. 5E, groups 4 and 5). The activity difference between non-phosphorylatable 
and phosphomimetic mutants of CREB-H-ΔTC suggested that phosphorylation at S87 and S90 might indeed be 
critical in governing β -TrCP recognition.
S73 and S77 are degron-proximal inhibitory phosphorylation sites of CREB-H-ΔTC. 
The presence of evolutionarily conserved serine residues in the flanking regions of the β -TrCP phosphodegron 
in CREB-H-ΔTC (Fig. 2A) prompted us to ask whether their phosphorylation might have regulatory roles in 
β -TrCP-dependent ubiquitination and degradation of CREB-H-ΔTC. In this regard, we noted that phosphoser-
ines and phosphothreonines adjacent to the degron in other β -TrCP substrates such as Snail, YAP and Nrf2 are 
also known to be influential in substrate recognition and degradation39–41.
To shed light on the roles of serine phosphorylation in the region of amino acid residues 73–77 proximal to 
the degron, we constructed non-phosphorylatable mutant CREB-H-ΔTC-MA, in which S73, S76 and S77 had 
been replaced by alanine. Opposite to this, a CREB-H-ΔTC-MD mutant with serine-to-aspartate substitution at 
the same three positions was also created (Fig. 6A). Notably, CREB-H-ΔTC-MA migrated faster on SDS-PAGE 
than CREB-H-ΔTC, whereas no noticeable change in the electrophoretic mobility rate of CREB-H-ΔTC-MD 
was found (Fig. 6B, lanes 2 and 3). The electrophoretic mobility shift indicated that one or more sites among S73, 
S76 and S77 might be post-translationally modified. Constitutive phosphorylation was most probable since the 
phosphomimetic form migrated as fast as the wild-type protein. Luciferase reporter assay confirmed the rise and 
fall of the transcriptional activity of CREB-H-ΔTC-MA and CREB-H-ΔTC-MD, respectively (Fig. 6C, groups 3 
and 4), indicating that phosphorylation of this region affects protein function.
We generated another mutant named CREB-H-ΔTC-A7, which contains both A4 and MA mutations 
(Fig. 6A). This mutant was not only as stable as CREB-H-ΔTC-A4 but also migrated as fast as CREB-H-ΔTC-MA 
(Fig. 6B, lanes 5–7). In addition, CREB-H-ΔTC-A7 had much higher transcriptional activity on the CRE-Luc 
reporter than CREB-H-ΔTC-A4 (Fig. 6D, groups 4 and 5), indicating the enhancing effect of the MA mutation 
on CREB-H-ΔTC-dependent transcription. When we used anti-V5 to pull down CREB-H-ΔTC and its mutants 
from cells, multiple protein species were found in the precipitates (Fig. 6E). Treatment with calf intestine phos-
phatase eliminated the multiple protein bands in the CREB-H-ΔTC and CREB-H-ΔTC-MA immunoprecipitates 
(Fig. 6F, lanes 2 and 4), providing crucial support to the phosphorylation of CREB-H-ΔTC.
To identify the exact phosphorylation sites among S73, S76 and S77, additional mutants were generated and 
tested. Because single mutants CREB-H-ΔTC-S73A, CREB-H-ΔTC-S76A and CREB-H-ΔTC-S77A only had 
weak phenotypes (data not shown), we introduced them in the background of CREB-H-ΔTC-A4 (Fig. 6A). 
Fast-migrating species of both CREB-H-ΔTC-S73A-A4 and CREB-H-ΔTC-S77A-A4 were observed in 
SDS-PAGE (Fig. 6G, lanes 2 and 4). In contrast, fast migration was not observed for CREB-H-ΔTC-S76A-A4, 
CREB-H-ΔTC-A4 or CREB-H-ΔTC (Fig. 6G, lanes 1, 3 and 5). Consistent with the electrophoretic mobility pat-
terns, transcriptional activities of CREB-H-ΔTC-S73A-A4 and CREB-H-ΔTC-S77A-A4 on the CRE-Luc reporter 
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were higher than that of CREB-H-ΔTC-A4 and close to that of CREB-H-ΔTC-A7 (Fig. 6H, groups 4, 6, 7 and 8). 
Taken together, our data suggested that both S73 and S77 are inhibitory phosphorylation sites of CREB-H-ΔTC.
Figure 5. Role of phosphodegron in SCFβ-TrCP-induced degradation of CREB-H-ΔTC. (A) A list of CREB-
H-ΔTC mutants. The mutation sites are underlined. (B,C) Co-immunoprecipitation. Plasmids expressing the 
indicated proteins were transfected into HEK293T cells. Cell lysates were immunoprecipitated with anti-V5. Both 
inputs (10%) and precipitates were probed with anti-FLAG and anti-V5. (D) Immunoblotting. (E) Luciferase 
reporter assay. Expression plasmids for CREB-H-ΔTC (ΔTC) and its mutants were individually transfected 
with luciferase reporter plasmid pCRE-Luc into HEK293T cells. The values of firefly luciferase were measured 
by luminescence and normalized with readings for Renilla luciferase. Data represent the means ± standard 
deviations of three independent measurements. Two tailed Student’s t test was performed to evaluate the 
statistical significance of the differences between the indicated groups. *p < 0.05. **p < 0.01. ***p < 0.001.
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Stabilized CREB-H-ΔTC exhibits enhanced transcriptional activity on target genes. Above we 
demonstrated a stabilizing effect of the A4 mutation on CREB-H-ΔTC (Fig. 6B, lane 6). This also correlated 
with a potentiating effect of the A4 mutation on the transcriptional activity of CREB-H-ΔTC on the CRE-Luc 
Figure 6. Influence of phosphodegron-proximal serine residues on CREB-H-ΔTC degradation. (A) A list 
of CREB-H-ΔTC mutants. The mutation sites were underlined. (B) Protein expression. Immunoblotting of cell 
lysates derived from HEK293T cells transfected with CREB-H-ΔTC and mutants was performed with anti-V5 
and anti-GAPDH. (C,D) Luciferase reporter assay. Luciferase reporter assay was carried out as in Fig. 5E.  
(E) Immunoprecipitation. HEK293T cells expressing CREB-H-ΔTC (V5-ΔTC) or its mutants were treated with 
10 μM MG132 for 3 hours before harvest. Protein samples were immunoprecipitated and probed with anti-V5. 
(F) CIP treatment. V5-CREB-H-ΔTC and V5-CREB-H-ΔTC-MA were transiently expressed in HEK293T cells. 
The protein lysates were immunoprecipitated with anti-V5. The precipitates were mock treated or treated with 
calf intestinal alkaline phosphatase (CIP) for 1 hour at 37 °C and analyzed by immunoblotting with anti-V5.  
(G) Immunoblotting of different CREB-H-ΔTC mutants. (H) Luciferase reporter assay. Luciferase reporter 
assay was performed as in Fig. 5E.
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reporter (Fig. 6D, group 4). In this part of our study we made use of the CREB-H-ΔTC-A4 mutant to investigate 
the impact of CREB-H-ΔTC stabilization on target gene transcription in cultured cells. We and others have pre-
viously identified phosphoenolpyruvate carboxykinase (PEPCK) gene as a target of CREB-H in the regulation of 
gluconeogenesis4,7. In addition, three genes critically involved in lipid metabolism, namely FGF21, FSP27β and 
APOA4, have recently been found to be CREB-H target genes in the liver12,18,20. On the other hand, CREB-H-ΔTC 
has also been shown to induce cell secretion and activate MMP13 gene transcription in HEK293 cells14. Hence, we 
chose these five genes for analysis of the transcriptional activity of CREB-H-ΔTC-A4. CREB-H-ΔTC was capable 
of activating the transcription of PEPCK, FGF21, FSP27β and APOA4 in HepG2 or Hep3B hepatoma cells as well 
as that of MMP13 in HEK293 cells, but the stimulating effect of CREB-H-ΔTC-A4 mutant was more pronounced 
on all five genes (Fig. 7A,C,E,G,I, groups 2 and 3). Consistent with the RT-qPCR results, the transcriptional activ-
ity of CREB-H-ΔTC-A4 as reflected in the expression of luciferase reporter driven by all five promoters was also 
higher than that of CREB-H-ΔTC (Fig. 7B,D,F,H,J, groups 2 and 3). Plausibly, stabilization of CREB-H-ΔTC led 
to enhancement of transcriptional activation of target genes both in magnitude and in duration.
To further verify the role of β -TrCP in the regulation of PEPCK gene expression, the two β -TrCP-targeting 
siRNAs were used to deplete endogenous β -TrCP expression in HepG2 cells. The knockdown effect was highly 
specific to β -TrCP and the siRNAs had no influence on the expression of CREB-H mRNA (Fig. 8A,B). By con-
trast, the expression of PEPCK transcript induced by CREB-H-ΔTC was significantly boosted when endogenous 
β -TrCP was depleted (Fig. 8C, groups 3 and 4). Thus, the activation of PEPCK gene expression by CREB-H was 
regulated by β -TrCP.
Discussion
In the present study, we uncovered a new mechanism by which SCFβ-TrCP ubiquitin ligase mediates the ubiquitina-
tion and degradation of CREB-H-ΔTC, the active form of liver-enriched transcription factor CREB-H. An evolu-
tionarily conserved β -TrCP phosphodegron with the SDSGIS motif was identified and characterized. In addition, 
the degron-proximal S73 and S77 were identified as the inhibitory phosphorylation sites for β -TrCP-dependent 
ubiquitination and degradation. Based on our findings, we propose a model for regulation of CREB-H-ΔTC activ-
ity (Fig. 9). In response to as yet uncharacterized physiological stimuli, CREB-H-ΔTC is phosphorylated sequen-
tially by two kinases, the second of which might be casein kinase II (CKII) as demonstrated in another study38. 
Phosphorylation by CKII at the degron is required for β -TrCP binding and recognition. According to our results, 
phosphorylation at three serine residues S85, S87 and S90 might be minimally required. In addition, inhibitory 
phosphorylation at S73 and S77 within the degron-proximal region, plausibly by glycogen synthase kinase 3 
(GSK-3) distinct from CKII as suggested in the other study38, also has regulatory function. CREB-H-ΔTC phos-
phorylated at S73 and S77 has low activity and is probably sensitized to subsequent degron phosphorylation by 
CKII leading to K48-linked polyubiquitination and proteasome-mediated degradation. As a result, transcription 
of CREB-H target genes, such as PEPCK, FGF21, FSP27β , APOA4 and MMP13, is down-regulated.
At the completion of our study, another work documenting SCFβ-TrCP-dependent degradation of CREB-H-ΔTC 
was published38. The two studies came to the same conclusion. The results presented were largely consistent and 
complementary. However, most of the mutants constructed and analyzed, some of the results obtained, as well as 
the emphases of the two papers were different. Whereas two kinases CKII and GSK-3 were identified in the other 
study, K48-linked polyubiquitination of CREB-H-ΔTC was analyzed in more detail in our work. On the other 
hand, the S87A S90A mutant was largely deficient for binding with β -TrCP in the other study38. In contrast, the 
β -TrCP-binding activity was unaffected in the same CREB-H-ΔTC-A2 mutant in our work, but a triple mutant 
CREB-H-ΔTC-A3 (i.e. S85A, S87A and S90A) lost the capability to bind with β -TrCP (Fig. 5C). Our results there-
fore suggested that S85, S87 and S90 in CREB-H-ΔTC might be minimally required for β -TrCP recognition. We 
are currently performing animal studies to clarify whether the CREB-H-ΔTC-A3 and CREB-H-ΔTC-A4 mutants 
are constitutively active and β -TrCP-dependent CREB-H-ΔTC degradation is physiologically relevant in vivo.
Although the two studies corroborated with each other to support the new model for SCFβ-TrCP-dependent 
ubiquitination and degradation of CREB-H-ΔTC, several questions remain unanswered. First, direct evidence for 
S85 phosphorylation is required although we have demonstrated the essential role of this residue in β -TrCP bind-
ing. Additional phosphorylation sites including S81, S95 and T100 also merit further analysis. Second, in addition 
to CKII and GSK-3 reported in the other study38, other kinases acting on the SDSGIS motif and its flanking regions 
remain to be identified and characterized. Based on bioinformatic analysis, we speculate that S73 and S77 might be 
phosphorylated by proline-dependent kinases in addition to GSK-3, whereas S87 and S90 might be targeted by aci-
dophilic serine kinases in addition to CKII42. Finally, the mechanism by which dephosphorylation of S73 and S77 
augments CREB-H-ΔTC activity remains unclear. In this regard, we have compared the subcellular localization of 
CREB-H-ΔTC and CREB-H-ΔTC-MA but both were found in the nucleus (data not shown), excluding the possi-
bility of cytoplasmic sequestration of CREB-H-ΔTC-MA. Other mechanisms should be explored in future study.
The relationship between the β -TrCP phosphodegron and its proximal region warrants further investi-
gations. One possibility is that phosphorylation of the degron-proximal region “primes” or sensitizes degron 
phosphorylation. Such “priming phosphorylation” has been found in many other β -TrCP substrates39,40,43. One 
example is Snail with a DS(0)GxxS(+4)xxxS(+8)xxS(+11) motif, in which the β -TrCP degron is bolded. In this case, 
priming phosphorylation at the serine residue at + 11 position is required for subsequent phosphorylation at 
serine residues at +8, +4 and 0 positions39,44. Another example is YAP, which contains an S(−3)TDS(0)GφS(+3) 
sequence. Here S(−3) served as a priming phosphorylation site for S(0) and S(+3)40. Considering that CREB-H-ΔTC 
contains an S(−14)xxxS(−10)xxxS(−6)xxxS(−2)DS(0)GφS(+3) sequence, S(−14)xxxS(−10)xxxS(−6) plausibly functions 
as the priming phosphorylation signal for subsequent S(−2)DS(0)Gφ S(+3) phosphorylation. Another possibility 
is that CREB-H-ΔTC, like CREB, contains a kinase-inducible domain45. Multiple kinases might phosphoryl-
ate S(−14)xxxS(−10)xxxS(−6)xxxS(−2)DS(0)GφS(+3)xxxxS(+8)xxxxT(+13) region to regulate CREB-H-ΔTC activity and 
stability.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:23938 | DOI: 10.1038/srep23938
Figure 7. Transcriptional activity of CREB-H-ΔTC and its mutant on target genes. PEPCK, FGF21, 
FSP27β , APOA4 and MMP13 mRNA expression in transfected HepG2, Hep3B or HEK293 cells were 
analyzed by RT-qPCR (panels A,C,E,G,I). Relative mRNA expression levels were normalized to the levels of 
β -tubulin transcript. Fold activation values represent the means ± standard deviations of three independent 
measurements. Concurrently, luciferase reporter assays were performed with the indicated reporters in HepG2, 
Hep3B and HEK293 cells as in Fig. 5E (panels B,D,F,H,J). Results are representative of triplicate experiments 
and error bars indicate the standard deviations. Statistical analysis was performed with two tailed Student’s t 
test. *p < 0.05. **p < 0.01.***p < 0.001.
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Figure 8. PEPCK gene expression in β-TrCP-depleted cells. The expression of PEPCK, β -TrCP and 
CREB-H transcripts in HepG2 cells transfected with two independent siRNAs targeting β -TrCP (siβ -T#1 
and siβ -T#2) and CREB-H-ΔTC (V5-ΔTC) construct. Relative mRNA expression levels were normalized 
to the levels of β -tubulin transcript. Fold activation values represent the means ± standard deviations of 
three independent experiments. Statistical analysis was performed with two tailed Student’s t test. *p < 0.05. 
**p < 0.01.***p < 0.001.
Figure 9. Working model for negative regulation of CREB-H-dependent transcription. Two kinases such 
as GSK-3 and CKII might be activated in response to physiological stimuli. The β -TrCP recognizing motif and 
its N-terminal adjacent region within CREB-H-ΔTC are phosphorylated. Phosphorylated CREB-H-ΔTC has 
low activity and is ultimately degraded through a β -TrCP-dependent pathway, leading to down regulation of the 
expression of CREB-H target genes.
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The phosphodegron of CREB-H-ΔTC, DS(0)Gφ S(+3), is very similar to but does not exactly match the canon-
ical β -TrCP-binding motif DS(0)Gφ xS(+4). However, several substrates without the x residue, such as RV-NSP1, 
YAP and Nrf2, have been identified, indicating that the x residue is not essential40,41,46. Interestingly, residue 
at −2 position of DS(0)Gφ S(+3) always prefers phosphorylatable residues (S, T or Y). Experimentally, we also 
demonstrated the requirement of S85 for the binding of CREB-H-ΔTC to β -TrCP. Thus, we propose the phos-
phorylatable residue at −2 position should be important for the binding of the SDSGφ S motif to β -TrCP. In other 
words, phosphorylation at −2 position might be “priming” degron phosphorylation at other sites. Alternatively, 
phosphorylation at −2 position could provide a negative charge to increase the binding of the SDSGφ S motif to 
β -TrCP. Previous studies have shown that negatively charged residue is most critical to β -TrCP binding47.
We have found that CREB3L4 contains the same β -TrCP recognizing sequence (SDSGIS) as CREB-H. In 
addition, the SDSDGS motif in CREB3L1 and the SDSEGS motif in CREB3L2 are very similar to the motif found 
in CREB-H. Plausibly, β -TrCP-mediated degradation is a common mechanism shared by most of these proteins. 
CREB3L1 and CREB3L2 are the substrates of Fbxw7. Both Fbxw7 and β -TrCP are F-box proteins of the SCF 
E3 ubiquitin ligase and they share many similar properties. Fbxw7 recognizes an S/TxxxS/T motif, in which 
S/T are phosphorylated48. It will be of interest to see whether Fbxw7 might also target CREB-H and CREB3L4. 
Interestingly, within CREB3L2 and CREB3L1 sequence, the reported Fbxw7-binding motif (TPPSS) is imme-
diately next to the putative β -TrCP-binding motif (Fig. 2B). Fbxw7 and β -TrCP can cooperatively degrade sub-
strates49. Thus, it will be intriguing to determine whether Fbxw7 and β -TrCP might cooperatively mediate the 
degradation of some CREB3 subfamily proteins.
The expression and activity of CREB-H are regulated at multiple levels including proteolytic activation, phos-
phorylation, ubiquitination and degradation. Most of the results are obtained with CREB-H-ΔTC in our study 
and in the other work38. CREB-H-ΔTC is the physiologically active form of CREB-H. The full-length CREB-H 
tethered to the ER membrane is an inactive protein with no transcriptional activity. However, since the phos-
phodegron and flanking regions are present in both CREB-H and CREB-H-ΔTC, it is not surprising if CREB-H 
degradation is regulated through the same mechanism. Indeed, we showed that CREB-H was also subjected to 
K48-linked polyubiquitination. Thus, CREB-H might also be targeted by β -TrCP in addition to other ER-bound 
E3 enzymes involved in ERAD. β -TrCP is an E3 ligase that plays an important role in the regulation of vari-
ous cell signaling pathways governing cell division, metabolism and oncogenesis29,31. Thus, our demonstration 
of β -TrCP-dependent ubiquitination and degradation of CREB-H-ΔTC provides new opportunities to explore 
how CREB-H degradation and activity are linked to other signal transduction pathways converging on β -TrCP. 
β -TrCP has been suggested as an important new target for anti-cancer therapy27. By the same reasoning, our 
findings also reveal a new strategy of controlling CREB-H activity by enhancing or decreasing the expression and 
activity of β -TrCP. For example, small-molecule activators and inhibitors of the two kinases that phosphorylate 
CREB-H-ΔTC could be harnessed for therapeutic modulation of the expression of CREB-H target genes.
Methods
Plasmids and primary antibodies. Expression plasmids pcDNA3.1-V5-CREB-H and pcDNA3.1-V5-
CREB-H-ΔTC for human CREB-H and CREB-H-ΔTC have been previously described4,11. Plasmid pCMV-
Tag2B-CREB-H-ΔTC was constructed by subcloning human CREB-H-ΔTC cDNA into pCMV-Tag2B (Agilent). 
Plasmid pcDNA3-FLAG-β -TrCP was kindly provided by Dr. Peter Howley (Harvard Medical School, MA, 
USA)50. β -TrCP cDNA was subcloned into pCAGEN vector with a V5 tag. pCMV-MYC-Ub and its mutant forms 
were derived from gifts of plasmids from Dr. Dirk Bohmann (University of Rochester Medical Center, NY, USA), 
Dr. Ted Dawson (Johns Hopkins University School of Medicine, MD, USA) and Dr. James Chen (University of 
Texas Southwestern Medical Center, TX, USA)51–53. pcDNA3-MYC3-CUL1 and pcDNA3-MYC3-RBX1 were 
supplied by Dr. Yue Xiong (School of Medicine, University of North Carolina at Chapel Hill, NC, USA)54,55. 
The promoter regions of FGF21 (−1033 ~ + 150), FSP27β (−808 ~ + 65), APOA4 (−763 ~ + 104) and MMP13 
(−1659 ~ + 23) were amplified from human genomic DNA and cloned into pGL3-basic (Promega). Primer 
sequences used for cloning are listed in Supplementary Table 1. Plasmid pSV-RLuc was purchased from Promega. 
Plasmids pCRE-Luc and pPEPCK-Luc have been described previously4.
Plasmid FLAG-β -TrCP-ΔFbox and plasmids expressing various CREB-H-ΔTC mutants were generated 
by site-directed mutagenesis using reagents supplied by Agilent. Mutagenic primers were designed using the 
web-based QuikChange Primer Design Program (www.agilent.com/genomics/qcpd; Agilent).
Primary antibodies used in this study included mouse anti-V5 (Invitrogen), rabbit anti-FLAG (F7425; 
Sigma-Aldrich), mouse anti-FLAG (M2; Sigma-Aldrich), rabbit anti-MYC (A-14; Santa Cruz), rabbit 
anti-glyceraldehyde-3-phosphatase dehydrogenase (anti-GAPDH: H12; Santa Cruz), rabbit anti-β -TrCP 
(D13F10; Cell Signaling) and rabbit anti-β -actin (Sigma-Aldrich).
Cell culture and transfection. Human hepatoma cell line Hep3B and human embryonic kidney cell lines 
HEK293 and HEK293T were cultured in Dulbecco’s Modified Eagle’s Medium containing 10% fetal bovine serum 
(Life Technologies). Human hepatoma cell line HepG2 was grown in Eagle’s Minimum Essential Medium (Life 
Technologies) supplemented with 10% fetal bovine serum. Transfection of cells was performed as previously 
described56,57.
For proteasome inhibition, transfected cells were treated with 10 μM MG132 (Calbiochem) for 6 hours before 
harvest. For protein turnover assay, 200 μM cycloheximide (Sigma-Aldrich) was added into transfected cells 
5 hours before harvest.
Immunoblotting. Forty-eight hours after transfection, cells were harvested in NP40 buffer (50 mM Tris-Cl, 
pH7.4, 250 mM NaCl, 1 mM EDTA, 1% NP-40 and 0.2% Triton X-100) supplemented with protease inhibitor 
cocktails (Roche). Protein concentration of cell lysates was determined by Bradford method (BioRad). Protein 
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samples were separated by SDS-PAGE, electroblotted onto polyvinylidene difluoride membranes (Millipore), 
incubated with primary and secondary antibodies, and visualized by enhanced chemiluminescence (Amersham).
Co-immunoprecipitation, phosphatase treatment and in vivo polyubiquitination. 
Co-immunoprecipitation was carried out as described58. Cells were lysed with NP40 buffer supplemented with 
protease inhibitor cocktails. Antibodies were recovered by incubating with recombinant protein G agarose 
(Invitrogen) for 2 hours, followed by overnight incubation with the remaining cell lysate at 4 °C. The protein G 
agarose was collected and washed at least three times with wash buffer (50 mM Tris-Cl, pH7.4, 800 mM NaCl, 
1 mM EDTA, 1% NP-40 and 0.2% Triton X-100) after incubation. The immunoprecipitates were separated by 
SDS-PAGE and analyzed by immunoblotting.
Phosphatase assay was performed as described59. HEK293T cells were cultured in 60 mm dishes and tran-
siently transfected with V5-CREB-H-ΔTC or its mutant forms. The protein lysates were incubated with mouse 
anti-V5 antibody and recombinant protein G agarose overnight. Next day the beads were rinsed with cold PBS 
and treated 10 units of calf intestine alkaline phosphatase (Fermentas) for 1 hour at 37 °C. After treatment, the 
beads were pelleted, washed twice with wash buffer and analyzed by immunoblotting.
For in vivo polyubiquitination, cells were co-transfected with the MYC-ubiquitin plasmid in combination 
with the wide-type or mutant V5-CREB-H-ΔTC plasmids. Forty-eight hours after transfection, total protein 
was collected, immunoprecipitated with anti-V5 antibody, resolved with SDS-PAGE and immunoblotted with 
anti-MYC antibody.
Luciferase reporter assay. Cells were harvested 36 hours after transfection for dual luciferase assay as 
previously described4,11. Transcriptional activity on cAMP response elements (CRE) as well as PEPCK, FGF21, 
FSP27β , APOA4 and MMP13 promoters was measured with reporter plasmids pCRE-Luc, pPEPCK-Luc, 
pFGF21-Luc, pFSP27β -Luc, pAPOA4-Luc and pMMP13-Luc, respectively. Transfection efficiencies were nor-
malized using a control plasmid pSV-RLuc.
RNA interference. RNA knockdown experiments were performed as described57. HepG2 and HEK293T 
cells were transfected with 100 nM siRNA using Lipofectamine 2000 (Invitrogen). The siRNA sequences are as fol-
lows: 5′ -AAGUGGAAUU UGUGGAACAU CdTdT-3′ for siβ -TrCP#143; 5′ -GAGAGAGAAG ACUGUAAUAdT 
dT-3′ for siβ -TrCP#2 and 5′ -GCUACCUGUU CCAUGGCCAdT dT-3′ for siGFP60,61.
Real-time PCR analysis. Total RNA was extracted from cells using the RNAiso Plus reagent (Takara) 
according to the manufacturer’s instructions and then incubated with DNase I (Ambion) to remove remaining 
genomic DNA. Reverse transcription was performed using the Transcriptor First Strand cDNA Synthesis rea-
gents (Roche). Real-time quantitative PCR was conducted in the presence of SYBR Premix Ex Taq (Takara) with 
the StepOnePlus real-time PCR system (Applied Biosystems). The mRNA level of β -tubulin was determined as 
an internal control and the results were analyzed using StepOne Software v2.3 (Applied Biosystems). Primer 
sequences used are listed in Supplementary Table 1.
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